SNGX
Soligenix Inc

12,709
Loading...
Loading...
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
16

Frequently Asked Questions

What is Market Cap of Soligenix Inc?
What is the 52-week high for Soligenix Inc?
What is the 52-week low for Soligenix Inc?
What is Soligenix Inc stock price today?
What was Soligenix Inc stock price yesterday?
What is the PE ratio of Soligenix Inc?
What is the Price-to-Book ratio of Soligenix Inc?
What is the 50-day moving average of Soligenix Inc?
How many employess does Soligenix Inc has?

Latest SNGX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.